Alamar Biosciences, Inc. (ALMR) stock
ALMRNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026
$30.51−0.13 (-0.42%)
Close on Nov 18, 2026Market cap $2.12BP/E –Yield –
Alamar Biosciences revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $33.55M | +107.6% |
| Q2 FY2026 | Jun 30, 2026 | $29.43M | +124.8% |
| Q1 FY2026 | Mar 31, 2026 | $26.04M | – |
| Q3 FY2025 | Sep 30, 2025 | $19.91M | – |
| Q2 FY2025 | Jun 30, 2025 | $16.16M | – |
| Q1 FY2025 | Mar 31, 2025 | $13.09M | – |
See a number that looks wrong?